Katelijn Vleugels is a serial entrepreneur and technology executive. She is passionate about the impact of rapidly advancing and converging technologies on the future of healthcare. She enjoys partnering with other entrepreneurs to build disruptive companies that extend healthspan and allow us to live happier, healthier and longer.
Katelijn most recently founded Klue, a technology company that seeks to simplify diabetes management and disrupt the $30B+ diabetes devices market. In 2019, Medtronic, the global leader in medical technologies, acquired Klue to help transform diabetes care, producing an IRR of more than 250% for Klue’s shareholders.
Katelijn received a Ph.D. degree in Electrical Engineering from Stanford University, where she also served as Consulting Professor in the Electrical Engineering Department between 2002 and 2013. She holds an M.S. degree in Electrical Engineering from the Katholieke Universiteit Leuven, Belgium, and an M.S. degree in Management, Science, and Engineering from Stanford University. In 2004, she co-founded Ozmo Devices. Katelijn was awarded a Franqui Foundation Fellowship by the Belgian American Education Foundation in 1997.